AviClear
AviClear - the first and only FDA-cleared energy device for treatment of mild, moderate and severe acne. Significantly eliminate acne in just three 30-minute treatment sessions*.
The future is clear and with AviClear, it just keeps getting better!
AviClear is the only treatment of its kind. Engineered with a revolutionary 1726 nm wavelength that's safe for all skin types, it selectively targets and suppresses the sebaceous glands, eliminating acne at the source without the need for prescription medications.
SIGNIFICANTLY ELIMINATE ACNE IN THREE, QUICK 30-MINUTE TREATMENT SESSIONS
Acne treatment just moved light years ahead
Clinical trials demonstrate that current and future breakout episodes are shorter, less intense, and more infrequent following the AviClear procedure. Further, acne clearance results continue to improve over time, demonstrating the long-term efficacy of this novel treatment.
To understand how AviClear works, it's important to understand how breakouts happen. Acne forms when sebum, the oils on your skin, combines with dead skin cells and clogs your pores. Most acne treatments target other things that cause acne, but not the production of sebum. And that makes a big difference in your results.
AviClear works differently
It is a laser treatment that specifically targets the source of the oils on your skin. After treatment, you will produce less oil and your acne will get better.
In clinical studies, 87% of patients saw at least half of their acne clear at six months after the final session. And results may continue to improve with time.
|
|
|
|
|
|
AviClear with laser Genesis
In clinical studies, about 15% of the patients experienced an acne flare-up after the first treatment and yes, sometimes, it gets worse before it gets better. By combining two technologies, Genesis and AviClear, we have been seeing incredible results in patients Median IGA1. score
* Please note no discount or promotion is applicable to AviClear. AviClear is not sold as individual sessions.
1. The IGA is a five-point scale that provides a global clinical assessment of AD severity ranging from 0 to 4, where 0 indicates clear, 2 is mild, 3 is moderate, and 4 indicates severe AD. A decrease in score relates to an improvement in signs and symptoms.